https://www.globenewswire.com/news-release/2026/09/17/3364155/0/en/novo-chmp-recommends-eu-approval-of-frehemgo-denecimig-the-first-factor-viiia-mimetic-offering-monthly-once-every-two-weeks-and-weekly-dosing-in-a-pre-filled-pen-for-the-treatment-.html